ArticleFrontiers in surgery2025
The anatomic feasibility of thoracic branched endoprosthesis in the treatment of blunt thoracic aortic injury.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Blunt thoracic aortic injury (BTAI) is one of the leading causes of death among trauma patients who sustain high impact thoracic trauma with rapid deceleration. Thoracic endovascular aortic repair (TEVAR) is indicated in high grade injuries and requires a management strategy for the left subclavian artery (LSA). Gore TAG thoracic branch endoprosthesis (TBE) is a newly approved TEVAR device for to maintain LSA patency utilizing a side branch with reported use in acute indications. The anatomic suitability of this device for a population of BTAI patients and optimal inventory for off-the-shelf emergent repairs has not been reported. Methods: A retrospective analysis of 66 patients admitted to a Level 1 Trauma Center who sustained BTAI between January 2011 and December 2023 and underwent TEVAR was performed. Computed tomography imaging was analyzed on all patients to determine the suitability for repair according to instructions for use (IFU) criteria of the manufacturer. Results: The distance between the LSA and the injury was less than 2 cm in 59% of patients, representing a possible indication for TBE. The average injury distance in this cohort was 9 mm from the LSA, with 82% of these patients meeting IFU requirements for TBE and 18% requiring standard TEVAR. For patients who met TBE graft requirements, 28 mm, 31 mm, and 34 mm aortic components fit 76% of patients and 10 mm and 12 mm subclavian branches fit 87% of patients. Patients who did not meet IFU requirements for TBE were sized for standard TEVAR with 26 mm, 31 mm, and 34 mm grafts treating 66% of patients. Conclusions: This study demonstrates key anatomic considerations and models the suitability and optimal TBE inventory drawn from a real-world population of BTAI patients. Despite a vast device catalog for TEVAR, this study demonstrates that carrying three TBE aortic components, two TBE subclavian components, and three standard TEVAR sizes would treat 71% of BTAI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.